Cargando…

Erratum: Kallikrein-related peptidase 8 is expressed in myocardium and induces cardiac hypertrophy

Detalles Bibliográficos
Autores principales:	Cao, Buqing, Yu, Qing, Zhao, Wei, Tang, Zhiping, Cong, Binhai, Du, Jiankui, Lu, Jianqiang, Zhu, Xiaoyan, Ni, Xin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Erratum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4850445/ https://www.ncbi.nlm.nih.gov/pubmed/27125362 http://dx.doi.org/10.1038/srep25038

Ejemplares similares

Kallikrein-related peptidase 8 is expressed in myocardium and induces cardiac hypertrophy
por: Cao, Buqing, et al.
Publicado: (2016)

A novel role of kallikrein-related peptidase 8 in the pathogenesis of diabetic cardiac fibrosis
por: Du, Jian-Kui, et al.
Publicado: (2021)

Erratum: Differential Diagnosis of Thick Myocardium according to Histologic Features Revealed by Multiparametric Cardiac Magnetic Resonance Imaging
por: Cha, Min Jae, et al.
Publicado: (2022)

CDC20 regulates cardiac hypertrophy via targeting LC3-dependent autophagy: Erratum
por: Xie, Yun-Peng, et al.
Publicado: (2021)

Erratum to “Anti-Interleukin-22-Neutralizing Antibody Attenuates Angiotensin II-Induced Cardiac Hypertrophy in Mice”
por: Ye, Jing, et al.
Publicado: (2018)

Erratum to effect of adenoid hypertrophy on the upper airway and craniomaxillofacial region
Publicado: (2022)

Erratum to: Changes of FGF23 and the Renin-Angiotensin-System in Male Mouse Models of Chronic Kidney Disease and Cardiac Hypertrophy
Publicado: (2022)

Erratum to “Inducible Conditional Vascular-Specific Overexpression of Peroxisome Proliferator-Activated Receptor Beta/Delta Leads to Rapid Cardiac Hypertrophy”
por: Wagner, Kay-Dietrich, et al.
Publicado: (2018)

Natural and synthetic inhibitors of kallikrein-related peptidases (KLKs)
por: Goettig, Peter, et al.
Publicado: (2010)

Metastasis of ovarian cancer is mediated by kallikrein related peptidases
por: Dong, Ying, et al.
Publicado: (2013)

Involvement of Kallikrein-Related Peptidases in Normal and Pathologic Processes
por: Stefanini, Ana Carolina B., et al.
Publicado: (2015)

Involvement of Kallikrein-Related Peptidases in Nervous System Disorders
por: Mella, Cinthia, et al.
Publicado: (2020)

Expression of kallikrein-related peptidase 7 is decreased in prostate cancer
por: Zhang, Chong-Yu, et al.
Publicado: (2015)

Erratum: Vol. 14 No. 8
Publicado: (2009)

Erratum Vol. 8, No. 1
Publicado: (2002)

Erratum: Vol. 70, No. 8
Publicado: (2021)

Kallikrein-related peptidase 7 is a potential target for the treatment of pancreatic cancer
por: Du, Jian Ping, et al.
Publicado: (2018)

Expression and function of the Kallikrein-related peptidase 6 in the human melanoma microenvironment
por: Krenzer, Stefanie, et al.
Publicado: (2011)

The use of kallikrein-related peptidases as adjuvant prognostic markers in colorectal cancer
por: Talieri, M, et al.
Publicado: (2009)

Radioimmunotherapy of prostate cancer targeting human kallikrein-related peptidase 2
por: Vilhelmsson Timmermand, O., et al.
Publicado: (2016)

Erratum, Vol. 8: Issue 5
Publicado: (2011)

Erratum, Vol. 8: Issue 6
Publicado: (2011)

Erratum: Vol. 68, No. SS-8
Publicado: (2019)

Myocardium-targeted transplantation of PHD2 shRNA-modified bone mesenchymal stem cells through ultrasound-targeted microbubble destruction protects the heart from acute myocardial infarction: Erratum
por: Sun, Zhenxing, et al.
Publicado: (2022)

Cardiac Rehabilitation in Real Life: Erratum
Publicado: (2015)

Erratum, Vol. 15, March 8 Release
Publicado: (2018)

Erratum for Euro Surveill. 2019;24(8)
Publicado: (2019)

Erratum, Vol. 13, December 8 Release
Publicado: (2017)

Erratum: Fetal cardiac arrhythmias: Current evidence
Publicado: (2018)

Kallikrein-Related Peptidases in Prostate Cancer: From Molecular Function to Clinical Application
por: Fuhrman-Luck, Ruth A., et al.
Publicado: (2014)

Kallikrein-Related Peptidase 6 Is Associated with the Tumour Microenvironment of Pancreatic Ductal Adenocarcinoma
por: Candido, Juliana B., et al.
Publicado: (2021)

Human Tissue Kallikreins-Related Peptidases Are Targets for the Treatment of Skin Desquamation Diseases
por: Zani, Marcelo B., et al.
Publicado: (2022)

Crocetin protects against cardiac hypertrophy by blocking MEK-ERK1/2 signalling pathway
por: Cai, Jun, et al.
Publicado: (2010)

Erratum: CAP2 in cardiac conduction, sudden cardiac death and eye development
por: Field, Jeffrey, et al.
Publicado: (2016)

Erratum to: Echocardiography and cardiac resynchronization therapy, friends or foes?
por: van Everdingen, W. M., et al.
Publicado: (2016)

Erratum: Psychiatric Characteristics of the Cardiac Outpatients with Chest Pain
por: Lee, Jae-Geun, et al.
Publicado: (2016)

Erratum to: The Use of Nuclear Imaging for Cardiac Resynchronization Therapy
por: Chen, Ji, et al.
Publicado: (2010)

Erratum to: Galectin-3 in Cardiac Remodeling and Heart Failure
por: de Boer, Rudolf A., et al.
Publicado: (2012)

Erratum: KJR 2007;8:365-371 Author's Correction
Publicado: (2008)

Doxycycline Indirectly Inhibits Proteolytic Activation of Tryptic Kallikrein-Related Peptidases and Activation of Cathelicidin
por: Kanada, Kimberly N., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_g7vai133v90t5urson8673tid6